[...] – Q2 2014 Merck Group | Business free cash flow by division – Q2 2014 Merck Group | Number of employees as of June 30, 2014: 39,230 As of June 30, 2014, Merck had 39,230 employees worldwide compared to 38,154 on December 31, 2013.
Merck conducts research and development worldwide in order to develop new products and services designed to improve the quality of life of patients and customers. Also in the second quarter of 2014, we focused on further optimizing the relevance and profitability of our research and development activities and we increased the number of new collaborations with external research and development partners. Nearly 4,000 employees around the world work for Merck researching innovations to serve long-term health and technology trends in established and emerging markets as well as in developing countries. Overall, the Merck Group invested around € 394 million in research [...]
[...] Merck has already begun with the integration of AZ and its global workforce of around 1,150 employees. With annual sales of around US$ 730 million in 2013, AZ is a leading supplier of high-tech materials with a production focus in Asia, where the company achieves nearly 80% of its sales. AZ generated more than three-quarters of its sales with products that are the leaders in their respective markets. Products from AZ are essential components of integrated circuits, flat-panel displays and light-emitting diodes. AZ is thus a key partner to leading global manufacturers of electronics since the chemical technologies AZ provides enable them to improve existing [...]
[...] the time value of Merck Share Units (MSUs). MSUs are virtual Merck shares that eligible executives and employees could receive at the end of a three-year performance period within the scope of the Merck Long-Term Incentive Plan. Income tax expenses of € 85 million (Q2 2013: € 101 million) led to a tax ratio of 21.7% (Q2 2013: 24.2%). Net income, i.e. profit after tax attributable to Merck shareholders, was € 303 million in the second quarter of 2014 (Q2 2013: € 316 million). Taking the share split into account, this resulted in earnings per share of € 0.70 (Q2 2013: € 0.73). XLS Merck Group | Reconciliation of EBIT to EBITDA pre one-time items € [...]
[...] silicon-chemistry-based products for optoelectronics. As of the end of 2013, AZ had a total of 1,131 employees. After May 2, 2014, Merck began to integrate AZ into the Performance Materials division. The aim of the acquisition is to further strengthen Merck’s materials and specialty chemicals business by joining forces with one the leading suppliers of high-tech materials for the electronics industry. The impact of the consolidation of AZ on sales as well as net income after taxes between May 2, 2014 and June 30, 2014 amounted to € 88.5 million and € -19.9 million, respectively. This result takes into account higher cost of sales owing to the step-up of the [...]
